HomeAI · summaries
Storia in 16 fonti
US probes Germany's drug pricing policies, opens door to tariffs
The US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and forces the US to shoulder a disproportionate share of global drug development costs. This investigation, under Section 301, could lead to new tariffs on Germany. Officials cite concerns that German policies suppress prices for innovative medicines, impacting research funding and potentially affecting American patients.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
US launches trade investigation into Germany over drug pricing
America has started a trade probe into Germany's plan to cut pharmaceutical spending. U.S. Trade Representative Jamieson Greer stated the investigation will determine if Germany's…
- ·
dw.com
US probes Germany's 'persistent underpayment' for drugs
The US Trade Representative said a new probe would determine if Germany was a underpaying for pharmaceuticals.
